https://www.ampulmonary.com/asthma/article/22971173/novel-peptide-could-eliminate-harmful-inflammation-at-its-sourcePulmonaryen2026-07-23T19:01:20.000ZNovel peptide could eliminate harmful inflammation at its sourcehttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/gettyimages-2231226744.WLuLMJR1zF.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/pulmonary/article/22970890/vitronectin-opens-door-to-novel-pf-therapiesPulmonaryen2026-07-23T18:58:00.000ZVitronectin opens door to novel PF therapieshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/gang-liu-uts.Q3cmqOfItg.jpg?auto=format%252Ccompress&q=70Gang Liu, PhDhttps://www.ampulmonary.com/asthma/article/22971171/kinaset-therapeutics-announces-first-patient-dosing-in-phase-2b-of-severe-asthma-trialPulmonaryen2026-07-23T18:55:49.000ZKinaset Therapeutics announces first patient dosing in phase 2b of severe asthma trialhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/gettyimages-1445996148.lDXo3Pw7Ed.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22971000/usage-of-copd-treatment-options-lower-among-black-populationPulmonaryen2026-07-21T18:37:46.000ZUsage of COPD treatment options lower among Black populationhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/copd-black-population.ORNgZl3Mow.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22970997/virtual-reality-could-help-ease-anxiety-and-depression-in-copd-patientsPulmonaryen2026-07-21T18:34:21.000ZVirtual reality could help ease anxiety and depression in COPD patientshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/vr-anxiety.tHjfZTV4Av.jpg?auto=format%252Ccompress&q=70